Home » Transgenomic Develops New Assays to Detect EGFR Mutations
Transgenomic Develops New Assays to Detect EGFR Mutations
Transgenomic, Inc. Monday announced completion of a development study of several new assays to detect genetic mutations using the company’s proprietary co-amplification at Lower Denaturing Temperature PCR technology in the Epidermal Growth Factor Receptor (EGFR) gene.
Earth Times
Earth Times
Upcoming Events
-
07May
-
14May
-
30May